Methods for treating autoimmune disorders, and reagents related thereto

Details for Australian Patent Application No. 2002360453 (hide)

Owner Trustees of Tufts College The Brigham and Women's Hospital, Inc.

Inventors Bachovchin, William W; Kuchroo, Vijay K

Agent Shelston IP

Pub. Number AU-B-2002360453

PCT Number PCT/US02/38347

PCT Pub. Number WO2003/045228

Priority 60/333,691 26.11.01 US

Filing date 26 November 2002

Wipo publication date 10 June 2003

Acceptance publication date 10 July 2008

International Classifications

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61K 31/401 (2006.01) - Proline

A61K 31/69 (2006.01) - Boron compounds

A61K 38/05 (2006.01) Medicinal preparations containing peptides - Dipeptides

A61P 1/00 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 5/14 (2006.01) Drugs for disorders of the endocrine system

A61P 7/00 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 13/12 (2006.01) Drugs for disorders of the urinary system

A61P 17/00 (2006.01) Drugs for dermatological disorders

A61P 19/02 (2006.01) Drugs for skeletal disorders

A61P 19/04 (2006.01) Drugs for skeletal disorders

A61P 21/04 (2006.01) Drugs for disorders of the muscular or neuromuscular system

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 31/18 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 37/00 (2006.01) Drugs for immunological or allergic disorders

A61P 37/02 (2006.01) Drugs for immunological or allergic disorders

A61P 37/08 (2006.01) Drugs for immunological or allergic disorders

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

Event Publications

3 April 2003 Complete Application Filed

  Priority application(s): 60/333,691 26.11.01 US

21 August 2003 Application Open to Public Inspection

  Published as AU-B-2002360453

2 December 2004 Amendment Made

  The nature of the amendment is: Amend the name of the co-applicant from Brigham and Women's Hospital to The Brigham and Women's Hospital, Inc. 2003

10 July 2008 Application Accepted

  Published as AU-B-2002360453

24 July 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under reg. 22.2E(2). This application has been accepted or advertised accepted. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

31 July 2008 Section 223 Application Allowed

  Trustees of Tufts College; The Brigham and Women's Hospital, Inc. The time in which to pay the exam response fee has been extended to 30 Jul 2008. Address for service in Australia - Shelston IP 60 Margaret Street Sydney NSW 2000 2003

6 November 2008 Standard Patent Sealed

22 January 2009 Application for Amendment

  The nature of the amendment is as shown in the statement(s) filed 22 Dec 2008. Address for service in Australia - Shelston IP 60 Margaret Street Sydney NSW 2000

18 June 2009 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 22 Dec 2008 2003

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002360454-METHODS AND COMPOSITIONS FOR TREATING CANCER USING 2192, 2193, 6568, 8895, 9138, 9217, 9609, 9857, 9882,10025, 20657, 21163, 25848, 25968, 32603, 32670, 33794, 54476 AND 94710

2002360452-SINGLE NUCLEOTIDE POLYMORPHISMS AND COMBINATIONS THEREOF PREDICTIVE FOR PACLITAXEL RESPONSIVENESS